-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634.P1.44 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I

Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Eli L. Diamond, MD1*, Benjamin Durham, MD, PhD2*, Ahmet Dogan, MD, PhD3, Mariko Yabe, MD, PhD4*, Kseniya Petrova-Drus, MD, PhD3*, Raajit K. Rampal, MD, PhD5, Raajit K. Rampal, MD, PhD5, Gary Ulaner6*, Mario Lacouture, MD7*, Veronica Rotemberg8*, Anne Covey2*, Lynn Brody9* and Omar Abdel-Wahab, MD10

1Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
5Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Institute, New York, NY
6Hoag Family Cancer Institute, Newport Beach, CA
7Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
9MSKCC, New York, NY
10Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Lucia Masarova, MD1, Meixian Huang2*, Sharon Bledsoe1*, Naveen Pemmaraju, MD1, Tapan M. Kadia, MD1, Prithviraj Bose, MD1, Jo Ishizawa, MD, PhD1, Guillermo Montalban-Bravo, MD1, Mi-Ae Lyu2*, Ke Zeng, MD2*, Tara Sadeghi3*, Ekatherine Asatiani, MD4, Simrit Parmar, MBBS2, Christopher R. Flowers, MD, MS2 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Cellenkos Inc., Houston, TX
4Incyte Corporation, Wilmington, DE

Yi Zhang1*, Hu Zhou, MD2*, Zhongxing Jiang3*, Dengshu Wu4*, Junling Zhuang, MD, PhD5, Wei Li6*, Qian Jiang, MD7, Xiuli Wang8*, Jinwen Huang9*, Huanling Zhu10*, Linhua Yang, MD11*, Xin Du12*, Fei Li13*, Ruixiang Xia14*, Feng Zhang15*, Jianda Hu16, Yan Li17*, Yu Hu, MD18*, Jing Liu, PhD19*, Chenghao Jin20*, Kai Sun21*, Zeping Zhou22*, Shanshan Suo, MD23*, Wenjuan Yu, MD1* and Jie Jin, MD1

1Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Henan Cancer Hospital/The Affiliated Cancer Hospital of Zheng Zhou University, Zhengzhou, China
3The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
4Department of Hematology, Xiangya Hospital, Central South University, Changsha, China
5Peking Union Medical College Hospital,Chinese Academy of Medical Sciences, Beijing, China
6The First Hospital of Jilin University, Changchun, China
7Peking University of People's Hospital, BEIJING, China
8Department of Oncology Hematology, The Second Hospital of Jilin University, Changchun, China
9Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
10Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
11Department of Hematology, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, China
12Guangdong Provincial People's Hospital, Guangzhou, China
13The First Affiliated Hospital of Nanchang University, Nanchang, China
14The First Affiliated Hospital of Anhui Medical University, Hefei, China
15Department of Hematology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
16Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
17Department of Hematopathology, The First Affiliated Hospital of China Medical University, Shenyang, China
18Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
19Department of Hematology, The Second Xiangya Hospital, Molecular Biology Research Center, School of Life Sciences, Hunan Province Key Laboratory of Basic and Applied Hematology, Central South University, Changsha, China
20Department of Hematology, Jiangxi Provincial People's Hospital, Nanchang, China
21Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, China
22Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
23Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;, Hangzhou, China

Naseema Gangat, MBBS1, Omer Karrar1*, Maymona Abdelmagid2*, Moazah Iftikhar1*, Kaaren K. Reichard, MD3, Natasha Szuber, MD, MSc4 and Ayalew Tefferi, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rochester, MN
3Division of Hematopathology, Mayo Clinic, Rochester, MN
4Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

Giacomo Coltro, MD1,2*, Raffaella Santi, MD3*, Giuseppe Gaetano Loscocco, MD1,2*, Alessandro Atanasio, MD2,4*, Paolo Cicogna, MD2,4*, Paola Guglielmelli, MD, PhD2,5, Umberto Gianelli, Prof6* and Alessandro M. Vannucchi, MD7,8*

1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
3Pathology Section, Department of Health Sciences, University of Florence, Florence, Italy
4University of Florence, Florence, Italy
5CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
6Department of Health Sciences, University of Milan, Milano, Italy
7University of Florence, CRIMM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
8CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

Pavlina Chrysafi, MD1, Kevin Barnum, MD, PhD2*, Genevieve Gerhard, MD3*, Thita Chiasakul, MD4*, Arshit Narang5*, Megan McNichol6*, Nicoletta Riva, MD, PhD7*, Walter Ageno, MD8*, Jeffrey I. Zwicker, MD9 and Rushad Patell, MBBS10

1Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA
2Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Beth Israel Deaconess Medical Center, Boston, MA
4Center of Excellence in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
5All India Institute of Medical Sciences, New Delhi, India
6Department of Information Systems, Division of Knowledge Services, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
7Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
8Department of Medicine and Surgery, University of Insubria, Varese, Italy
9Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA
10Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Sung-Yong Kim, MD, PhD1*, Sung-Eun Lee, MD2*, Junshik Hong, MD3, Soo-Mee Bang, MD, PhD4, Jinny Park5*, Chul Won Choi6*, Sung Hwa Bae, MD7*, Min Kyoung Kim, MD8* and Seug Yun Yoon9*

1Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Seoul, South Korea
2Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Seoul National University Hospital, Seoul National University College of Medicine, Seoul, KOR
4Seoul National University Bundang Hospital, Seongnam-si, KOR
5Gil Medical Center Gachon University, Inchon, KOR
6Department of Internal Medicine, Korea University Medical Center, Seoul, KOR
7Department of Internal Medicine, Daegu Catholic, University Hospital, Daegu Catholic University School of Medicine, Daegu, KOR
8Yeungnam University Hospital, Daegu, Korea, Republic of (South)
9Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, New Jersey, KOR

Katie Erdos1*, Neville Lee Jr.1*, Ahamed Lebbe2*, Imane Bouhali2*, Mohammed Khalid2*, Ghaith Abu-Zeinah, MD1, Richard T. Silver, MD1 and Joseph M. Scandura, MD, PhD, MS1

1Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
2Weill Cornell Medicine - Qatar, Doha, Qatar

Rami S. Komrokji, MD1, Aaron T. Gerds, MD, MS2, Claire N Harrison3, Jean-Jacques Kiladjian, MD, PhD4, Ruben A. Mesa, MD5, Prithviraj Bose, MD6, Fabian Sanabria7*, Niloufar Marsousi7*, Ana Carolina Giuseppi8*, Huijing Jiang8* and Francesco Passamonti9*

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Cleveland Clinic, Cleveland, OH
3Guy's and Saint Thomas' NHS Foundation Trust, London, United Kingdom
4Hopital Saint-Louis, Paris, France
5Wake Forest Baptist Comprehensive Cancer Center, Medical Center Blvd, Winston-Salem, NC
6MD Anderson Cancer Center, The University of Texas, Houston, TX
7Bristol Myers Squibb, Boudry, Switzerland
8Bristol Myers Squibb, Princeton, NJ
9University of Milano Statale, Milan, Italy

Giacomo Coltro, MD1,2*, Raffaella Santi, MD3*, Alessandro Atanasio, MD2,4*, Paolo Cicogna, MD2,4*, Paola Guglielmelli, MD, PhD2,5, Umberto Gianelli, Prof6* and Alessandro M. Vannucchi, MD7,8*

1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
3Pathology Section, Department of Health Sciences, University of Florence, Florence, Italy
4University of Florence, Florence, Italy
5CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
6Department of Health Sciences, University of Milan, Milano, Italy
7University of Florence, CRIMM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
8CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

Daehun Kwag1*, Gi-June Min1*, Sung-Soo Park2*, Silvia Park3*, Jae-Ho Yoon, MD1, Byung-Sik Cho1*, Ki-Seong Eom1*, Yoo-Jin Kim1, Seok Lee1, Hee-Je Kim1, Chang-Ki Min1*, Seok-Goo Cho1*, Jong-Wook Lee, MD4 and Sung-Eun Lee, MD5*

1Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
4Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, South Korea
5Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX

Miriam Kimpton, MD, MSc1, Sonia Cerquozzi, MD2, Dominique Toupin, MD3*, Pierre Villeneuve, MD, PhD, FRCPC1, Deborah Siegal, MD, MSc1, Marc Carrier, MD, MSc1 and Aurelien Delluc, MD, PhD1*

1The Ottawa Hospital, Ottawa, ON, Canada
2Alberta Health Services, Rochester, AB, CAN
3Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Canada

Chen Jia1*, Huan Dong1*, Ting Sun1*, Rongfeng Fu1*, Renchi Yang, MD2 and Lei Zhang, MD3

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China

Tomoki Ito, MD, PhD1, Teruhito Takakuwa, MD, PhD2*, Masayuki Hino, MD, PhD2*, Hirohisa Nakamae, MD, PhD3* and Tadashi Matsuura, PhD4*

11st. Department of Internal medicine, Kansai Medical University, Hirakata, Japan
2Department of Hematology, Osaka Metropolitan University, Osaka, Japan
3Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan
4Perseus Proteomics Inc., Tokyo, Japan

Ruben A. Mesa, MD1, Moshe Talpaz, MD2, Flora Mazerolle, MSc3*, Boris Gorsh, PharmD4*, Manal M'Hari, MSc3*, Antoine Regnault, PhD3*, Catherine Ellis, BS4*, Zhaohui Wang, MS4*, Molly Purser, PhD, MBA4*, Tom Liu, MS4*, Bryan Strouse, MS4* and Dwaipayan Patnaik, MD, MBBS5

1Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
2University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
3Modus Outcomes, Lyon, France
4GSK plc, Collegeville, PA
5GSK, Baar, Switzerland

Marianna Criscuolo1*, Patrizia Chiusolo1,2*, Luana Fianchi, MD, PhD3*, Antonio Giordano, MD4*, Matteo Bonanni, MD2,5*, Alessia Di Pilla, MD2,6*, Maria Colangelo, MD7*, Monica Rossi, MD8*, Gessica Minnella, MD1*, Tanja Malara, MD6*, Luigi Maria Larocca, MD9*, Andrea Bacigalupo, MD10 and Livio Pagano, MD3,11*

1Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
2Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
3Dipartimento di Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
4Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, ROMA, ITA
5Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ITA
6Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
7UOC Genetica Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
8Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
9Università Cattolica Del Sacro Cuore, Rome, ITA
10Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ITA
11Università Cattolica del Sacro Cuore, Roma, Italy

Ganesh Sivakumar, MD1*, Shivani Handa, MD2, Andrew Srisuwananukorn, MD3, Douglas Tremblay, MD2, John Mascarenhas, MD4*, Marina Kremyanskaya, MD, PhD2, Yelena Ginzburg, MD2, Xiaoli Wang, MD, PhD2 and Ronald Hoffman, MD4

1Department of Internal Medicine, Icahn School of Medicine/ Mount Sinai Morningside-West, New York, NY
2Division of Hematology & Medical Oncology, Tisch Cancer Institute/ Icahn School of Medicine at Mount Sinai, New York, NY
3Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Zefeng Xu1*, Ling Pan2*, Zhenya Hong, MD3*, Qingsong Yin, PhD4*, Xuelan Zuo, MD5*, Qin Wen, MD6*, Fan Yu, MD7*, Chunkang Chang, MD8*, Wei Ling, MD9*, Dong Wang10*, Dawei Ding10* and Zhijian Xiao, MD1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin Institutes of Health Science, Tianjin, China
2Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
3Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
4Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
5Zhongnan Hospital of Wuhan University, Wuhan, China
6Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
7Beijing Tsinghua Changgung Hospital, Beijing, China
8Shanghai Sixth People's Hospital, Shanghai, China
9Guangdong Provincial People’s Hospital, Guangdong, China
10Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China

Douglas Tremblay, MD1, Zaker I. Schwabkey, MD2, Yosef Joseph Rene Amel Riazat-Kesh, MD1*, Grace Van Hyfte3*, Najla H Al Ali, MS4*, Julian Waksal, MD1, Andrew Srisuwananukorn, MD5, Rami S. Komrokji, MD4, John Mascarenhas, MD1* and Andrew T. Kuykendall, MD2

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Moffitt Cancer Center, Tampa, FL
3Icahn School of Medicine At Mount Sinai, New York, NY
4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
5Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Yuka Sugimoto, MD, PhD1, Keiki Nagaharu, MD, PhD2,3*, Eiko Oya, MD3,4*, Kohshi Ohishi, MD, PhD5, Isao Tawara, MD, PhD3, Tomoki Ito, MD, PhD6, Akihiko Gotoh, MD, PhD7, Mika Nakamae, MD, PhD8*, Fumihiko Kimura, MD, PhD9, Michiaki Koike, MD, PhD10*, Keita Kirito, MD11, Hideho Wada, MD, PhD12*, Kensuke Usuki, MD, PhD13, Takayuki Tanaka, MD, PhD14*, Takehiko Mori, MD, PhD15,16*, Satoshi Wakita, MD, PhD17*, Toshiki I Saito, MD, PhD18*, Akiko Kada, PhD18*, Akiko M Saito, MD, PhD18*, Kazuya Shimoda, MD, PhD19, Toshio Kurokawa, MD, PhD20*, Akihiro Tomita, MD, PhD21*, Yoko Edahiro, MD, PhD22*, Yoshinori Hashimoto, MD, PhD14*, Hitoshi Kiyoi, MD, PhD23, Koichi Akashi, M.D., Ph.D.24*, Itaru Matsumura, MD, PhD25, Katsuto Takenaka26 and Norio Komatsu, MD, PhD,27,28

1Department of Hematology and Oncology, Mie University, Tsu City, Mie Prefecture, Japan
2Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, JPN
3Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
4Department of Hematology, Matsusaka Chuo General Hospital, Matsusaka, Japan
5Transfusion Medicine and Cell Therapy, Mie University Hospital, Tsu, Mie, JPN
61st. Department of Internal medicine, Kansai Medical University, Hirakata, Japan
7Department of Hematology, Tokyo Medical University, Tokyo, JPN
8Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, JPN
9Division of Hematology, National Defense Med. College, Tokorozawa, JPN
10Department of Hematology, Juntendo University Shizuoka Hospital, Izunokuni, Japan
11Department of Hematology and Oncology, University of Yamanashi, Chuo, Japan
12Department of Hematology, Kawasaki Medical School, Kurashiki, JPN
13NTT Medical Center Tokyo, Tokyo, Japan
14Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan
15Division of Hematology, Keio University School of Medicine, Tokyo, Japan
16Department of Hematology, Tokyo Medical and Dental University School of Medicine, Bunkyo-Ku, JPN
17Hematology, Internal Medicine, Nippon Medical School, Tokyo, JPN
18Clinical Research Center, NHO Nagoya Medical Center, Nagoya, JPN
19University of Miyazaki, Miyazaki, Japan
20Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan
21Department of Hematology, Fujita Health University School of Medicine, Toyoake, JPN
22Department of Hematology, Juntendo University School of Medicine, Tokyo, JPN
23Nagoya University Graduate School of Medicine, Nagoya, Japan
24Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
25Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, JPN
26Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, Japan
27Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
28PharmaEssentia Japan KK, Tokyo, Japan

Joseph Tripodi, PhD1, Ronald Hoffman, MD2, Douglas Tremblay, MD3, John Mascarenhas, MD4*, Marina Kremyanskaya, MD, PhD5, Ian Novoselac6* and Vesna Najfeld, PhD4,7

1Department of Pathology, Molecular and Cell-Based Medicine, The Icahn School of Medicine at Mount Sinai, Old Tappan, NJ
2Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
3Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, NY
4Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
5Division of Hematology & Medical Oncology, Tisch Cancer Institute/ Icahn School of Medicine at Mount Sinai, New York, NY
6The Department of Pathology, Molecular and Cell-Based Medicine, The Mount Sinai Hospital, New York, NY
7Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

Baptiste Le Calvez1,2*, Maxime Jullien, MD3,4*, Jean-Hugues Dalle5*, Cécile Renard, MD6*, Charlotte Jubert, MD7*, Arthur Sterin8*, Catherine Paillard9*, Anne Huynh, MD10*, Sarah Guenounou, MD11*, Benedicte Bruno12*, Virginie Gandemer13*, Nimrod Buchbinder14*, Pauline Simon15*, Cecile Pochon16*, Anne Sirvent, MD17*, Dominique Plantaz18*, Justyna Kanold19*, Fanny Rialland Battisti20* and Audrey Grain, MD1,2*

1Pediatric Hematology, Nantes, France
2Nantes University, Inserm UMR 1307, CNRS UMR 6075, Angers University, CRCI2NA, Nantes - France, Nantes, France
3Inserm UMR 1307, CNRS UMR 6075 - Team 12, Nantes University, Nantes, MD, France
4Nantes University Hospital, NANTES, France
5Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
6Institute of Hematology and Pediatric Oncology, Lyon, France
7Hématologie et oncologie pédiatrique, CHU de Bordeaux, Bordeaux Cedex, FRA
8APHM, La Timone Children Hospital, Department of Pediatric Hematology, Immunolog, Marseille, FRA
9CHRU Strasbourg, Strasbourg, FRA
10Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
11CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
12Chru Lille, Jeanne De Flandre Hématologie Pédiatrique, Lille, FRA
13CHU Hopital Sud, Rennes, FRA
14Rouen University Hospital, Rouen, FRA
15Hématologie et oncologie pédiatrique, CHRU de Besancon, Besancon, France
16Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandoeuvre-les-Nancy, France
17CHU Montpellier, Montpellier, France
18CHU Grenoble, Grenoble, France
19CHU Clermont Ferrand, Clermontferrand, FRA
20Hématologie et oncologie pédiatrique, CHU Hôtel Dieu, Nantes, FRA

Johannes Luebke, MD1*, Nicole Naumann, PhD1*, Timo Brand, MD1*, Hans-Peter Horny, MD2*, Martina Rudelius2*, Karl Sotlar, MD3*, Georgia Metzgeroth, MD1*, Alice Fabarius, PhD1*, Wolf-Karsten Hofmann, MD1, Juliana Schwaab4* and Andreas Reiter, MD5

1Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
2Institute of Pathology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany
3University Hospital, Paracelsus Medical University, Salzburg, AUT
4Department of Hematology and Oncology, Iii.Medizinische Klinik, Mannheim, Germany
5Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany

Tong-Yoon Kim1*, Sung-Eun Lee, MD2*, Gi-June Min3*, Sung-Soo Park3*, Silvia Park4*, Jae-Ho Yoon, MD3, Byoung Sik Cho4*, Yoo-Jin Kim3, Ki-Seong Eom3*, Seok Lee3, Hee-Je Kim5*, Chang-Ki Min3*, Seok-Goo Cho4*, Jong-Wook Lee, MD3, Jongmi Lee6*, Myungshin Kim7* and Ji Yoon Lee8*

1Department of Hematology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Seoul, KOR
2Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
5Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Korea, Republic of (South)
6Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Seoul, KOR
7Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
8Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea, Seoul, Korea, Republic of (South)

Shiwei Hu1*, Xiudi Yang, MD1*, Jingjing Zhu, MD1* and Jian Huang2,3

1Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China;, Hangzhou, China
3Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;, Hangzhou, China

Mael Heiblig1*, Clement Gourguechon2*, Philippe Guilpain3*, Cristina Bulai Livideanu4*, Stéphane Barete, MD, PhD5*, Julie Agopian6*, Fabienne Brenet, PhD7*, Patrice Dubreuil7*, Richard Lemal8*, Olivier Tournilhac9*, Louis Terriou, MD PhD10*, David Launay, Pr11*, Laurence Bouillet, Pr12*, Gandhi Laurent Damaj, MD, PhD13*, Thomas Ballul14*, Céline Greco15*, Laura Polivka, MD, MSc16*, Laurent Frenzel, MD, PhD17*, Cecile Meni18*, Hassiba Bouktit19*, Caroline Gaudy-Marqueste, Pr20*, Marie Gousseff21*, Edwige Le Mouel22*, Antoine Neel, Pr23*, Dana Ranta24*, Roland Jaussaud, Pr25*, Thierry Jo Molina, MD, PhD26*, Julie Bruneau27*, Ludovic Lhermitte28*, Marie Temple29*, Olivier Kosmider, PharmD, PhD30*, Rose-Marie Javier31*, Fabien Pelletier32*, Florence Castelain33*, Frédérique Retornaz34*, Quentin Cabrera35*, Patricia Zunic36*, Marie-Pierre Gourin, MD37*, Ewa Wierzbicka-Hainaut38*, Jean-Francois Viallard, MD PhD39*, Christian Lavigne40*, Cyrille Hoarau41*, Isabelle Durieu42*, Sophie Dimicoli-Salazar43*, Jose-Miguel Torregrosa-Diaz44*, Angele Soria, Pr45*, Michel Arock, Pr46*, Christine Bodemer47*, Olivier Lortholary, Pr48*, Olivier Hermine, MD, PhD49,50 and Julien Rossignol51*

1Hematology Department, Hôpital Lyon Sud, Vourles, Rhône Alpes, France
2Amiens University Hospital, Amiens, France
3Montpellier University Hospital, Montpellier, FRA
4Department of Dermatology, CEREMAST Toulouse, CHU Toulouse, Toulouse, France
5AP-HP, Pitié-salpêtrièRe Hospital, University Pierre & Mari, Paris, France
6Centre De Recherche En CancéRologie De Marseille - AFIRMM, Marseille, FRA
7Oncométabolisme dans les hémopathies malignes, Centre de Recherche en Cancérologie de Marseille, Marseille, France
8Centre hospitalier universitaire de Clermont-Ferrand, Clermont Ferrand, FRA
9CHU de Clermont-Ferrand, CLERMONT FERRAND, AURA, FRA
10Lille University Hospital, Lille, FRA
11Service de médecine interne, CHRU de Lille, Lille, France
12Service de médecine interne, CHU de Grenoble, Grenoble, France
13CHU Caen, Caen, Normandy, FRA
14Service de médecine interne, Hôpital Necker-Enfants Malades, Paris, France
15Douleur et médecine palliative, Hôpital Necker-Enfants Malades, Paris, FRA
16Institut Imagine, Hôpital Necker-Enfants Malades, PARIS, FRA
17Department of Haematology, Institut Necker, Paris, FRA
18AP-HP5, Paris, FRA
19CEREMAST, Hôpital Necker-Enfants Malades, Paris, France
20Service de Dermato Oncologie, Dermatologie Générale et Vénéréologie, Hôpital de la Timone, Marseille, France
21Médecine interne et maladies infectieuses, Centre Hospitalier Bretagne Atlantique, Vannes, France
22Médecine Interne et Immunologie Clinique, Centre Hospitalier Universitaire de Rennes, Rennes, FRA
23Service de Médecine Interne-Médecine Vasculaire, CHU de Nantes, Nantes, France
24Hématologie, CHRU NANCY, Vandoeuvre Les Nancy, FRA
25Service de médecine interne et immunologie clinique, CHRU de Nancy, Vandoeuvre-Les-Nancy, France
26Necker enfants malades, APHP, Paris, Paris, France
27Anatomie pathologique, Hôpital Necker-Enfants Malades, Paris, France
28Laboratory of Onco-Hematology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
29Hématologie Biologique, Hôpital Cochin, Paris, France
30Laboratory of Hematology, Université Paris Cité and Assistance Publique-Hôpitaux de Paris. Centre, Hôpital Cochin, Paris, France
31Service de rhumatologie, CHRU Strasbourg, Strasbourg, FRA
32Service de Dermatologie, maladies sexuellement transmissibles, allergologie et explorations cutanées, CHU Besançon, Besançon, France
33DERMATOLOGIE, MALADIES SEXUELLEMENT TRANSMISSIBLES, ALLERGOLOGIE ET EXPLORATIONS CUTANÉES, CHU Besançon, BesançOn, FRA
34Pôle hématologie, infectiologie et médecine interne, Hôpital Européen Marseille, Marseille, France
35Hématologie, CHU Sud Réunion, Saint Pierre, Reunion
36Centre Hospitalier Universitaire de La Réunion - Saint-Pierre, St Pierre, France
37CHU Limoges, Limoges, FRA
38Unité de dermatologie Service de Dermatologie et dermato-allergologi, CHU Poitiers, Poitiers, France
39Service Médecine Interne, Haut-Leveque Hospital, Pessac, France
40Angers University Hospital, Angers, France
41Immunologie, Université de Tours, Tours, FRA
42Service de Médecine Interne, Université De Lyon- Hospices Civils De Lyon, Pierre Benite, France
43Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
44Hématologie, CHU Poitiers, Poitiers, France
45Dermatologie, allergologie et médecine vasculaire, Hôpital Tenon, Paris, France
46CHU PITIE SALPETRIERE, Paris, France
47Necker Enfant Malades Hospital, University Paris 5, Paris, FRA
48Medecine interne, Hôpital Necker-Enfants Malades, Paris, France
49INSERM U1163 and CNRS 8254, Imagine Institute, Université Sorbonne Paris Cité, Paris, France
50Department of Hematology, Hospital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Paris, France
51Hématologie, NECKER ENFANTS MALADES Hospital APHP, Paris, FRA

Fabrizio Cavalca1,2*, Ivan Civettini, MD3,4*, Stefano Bonfanti, MD3,4*, Carlo Gambacorti-Passerini, MD4,5 and Elena Maria Elli, MD6*

1Hematology Department, San Gerardo Hospital, Monza, Italy
2University of Milan-Bicocca, Milan, Italy
3Department of Medicine and Surgery, University Milano-Bicocca, Monza, Italy
4Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
5University Milano-Bicocca, Monza, Italy
6Hematology Division and Bone Marrow Unit, IRCCS Foundation San Gerardo dei Tintori, Monza, Italy., Monza, Italy

Rathnam K. Venkat, BA, BS1, Robert A. Redd, MS2*, Martin J. Aryee, PhD2,3*, Anna E. Marneth, PhD4,5, Baransel Kamaz, MD6*, Chulwoo J. Kim7*, Mohammed Wazir8, Lachelle D. Weeks, MD, PhD9, Maximilian Stahl, MD9, Daniel J. DeAngelo9, Coleman Lindsley, MD, PhD10, Marlise R. Luskin, MD, MSCE10, Gabriela S. Hobbs, MD11 and Joan How, MD5,9

1Tufts University School of Medicine, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Department of Laboratory Medicine, Division Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
5Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
6Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
7Department of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
8Umass Chan Medical School, Worcester, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
10Dana-Farber Cancer Institute, Boston, MA
11Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA

Atulya Aman Khosla, MBBS1, Nitya Batra, MBBS2*, Rohit Singh, MD3*, Karan Jatwani, MBBS4*, Akshee Batra, MBBS5*, Yanjia Zhang6*, Zhenwei Zhang7*, Md Ashfaq Ahmed6*, Mukesh Roy7*, Venkataraghavan Ramamoorthy6*, Muni Rubens, MD, PhD6*, Anshul Saxena6* and Diego Adrianzen Herrera, MD3

1Department of Internal Medicine, Beaumont Hospital (Royal Oak), Troy, MI
2William Beaumont Hospital, Royal Oak, MI
3Division of Hematology and Oncology, Larner College of Medicine at the University of Vermont, Burlington, VT
4Roswell Park Comprehensive Cancer Center, Buffalo
5Department of Internal Medicine, University of Vermont Medical Center, Winooski, VT
6Baptist Health South Florida, Miami
7Baptist Health South Florida, Miami, FL

Danijela Lekovic, MD, PhD1, Jelena Ivanovic2*, Isidora Arsenovic, MD3*, Mihailo Smiljanic, MD3*, Vladan P. Cokic4* and Andrija Bogdanovic, Professor1,3*

1Faculty of Medicine, University of Belgrade, Belgrade, Serbia
2Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia
3Clinic of Hematology, University Clinical Center Serbia, Belgrade, Serbia
4Department of molecular oncology, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia, Serbia

Roberto Latagliata1*, Gianluca Cristiano, MD2*, Dorela Lame, MD3*, Alda Strazimiri, MD4*, Fabrizio Cavalca5*, Lorenzo Rizzo, MD6*, Giulia De Luca, MD7*, Simone Zoletto, MD8*, Vincenzo Federico, MD9*, Daniele Cattaneo, MD10*, Annalisa Biagi, MD11*, Monica Crugnola, MD12*, Pasquale Niscola, MD13*, Raffaele Palmieri, MD14*, Anna Lina Piccioni, MD15*, Olga Mulas, MD16*, Beatrice Esposito Vangone, MD17*, Michelina Santopietro, MD18*, Ida Carmosino, MD19*, Alessandra Iurlo, MD, PhD20*, Nicola Di Rienzo, MD21*, Gianni Binotto, MD22*, Prassede Salutari, MD23*, Marta Riva, MD24*, Massimiliano Bonifacio, MD25*, Elena Maria Elli, MD26*, Antonio Curti, MD, PhD27 and Antonella Poloni, MD28*

1Hematology, Belcolle Hospital, Rome, Italy
2Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy
3Hematology, AOU Marche - Politecnic University Marche, Ancona, Italy
4Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy
5Hematology Department, San Gerardo Hospital, Monza, Italy
6Department of Hematology and Oncology, Niguarda Cancer Center, ASST Ospedale Nig, Milan, Illinois, ITA
7UOC Ematologia Clinica, Ospedale Civile "Santo Spirito", Pescara, Italy
8Hematology Unit, Department of Medicine, University of Padova, Padova, Italy
9Hematology, Vito Fazzi Hospital, Lecce, Italy
10Hematology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
11S.M. Goretti Hospital – Polo Pontino “Sapienza” University - Latina, Latina, Italy
12Hematology Unit and BMT, University Hospital of Parma, Parma, Italy
13Hematology Unit, Sant'Eugenio Hospital, Rome, Italy
14Department of Onco-Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy
15Dipartimento di Ematologia, Azienda Ospedaliera San Giovanni Addolorata, Rome, Italy
16Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
17UOC Ematologia, Azienda ospedaliero-universitaria Senese, Siena, Italy
18Hematology and Hematopoietic Stem Cells Transplant Unit, AO San Camillo-Forlanini, Rome, Italy
19Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
20Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
21UO EMATOLOGIA, ASL LECCE, OSPEDALE V. FAZZI, Lecce, Italy
22Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padua, Italy
23Department of Hematology, Ospedale Civile Spirito Santo, Pescara, Pescara, Italy
24Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda Cancer Center, Milano, Italy
25Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
26Fondazione IRCCS, San Gerardo dei Tintori, Monza, Monza, Italy
27IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
28Hematology, AOU Marche - Politecnic University Marche - Ancona, Ancona, ITA

Nico Gagelmann1*, Anita Badbaran2*, Christine Wolschke1*, Mathias Schäfersküpper3*, Dietlinde Janson4*, Francis A. Ayuk, MD5*, Boris Fehse, PhD6* and Nicolaus Kroeger, MD1

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2Department of stem cell transplantation, University Hospital Hamburg Eppendorf, Hamburg, DEU
3University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4Department of Stem Cell Transplantation, University Medical Center Hamburg Eppendorf, Hamburg, DEU
5Department of Stem Cell Transplantation with Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6University Medical Center Hamburg-Eppendorf, Hamburg, DEU

*signifies non-member of ASH